TY  - GEN
AU  - Papadakis,Emmanouil
AU  - Robson,Natalia
AU  - Yeomans,Alison
AU  - Bailey,Sarah
AU  - Laversin,Stephanie
AU  - Beers,Stephen
AU  - Sayan,A Emre
AU  - Ashton-Key,Margaret
AU  - Schwaiger,Stefan
AU  - Stuppner,Hermann
AU  - Troppmair,Jakob
AU  - Packham,Graham
AU  - Cutress,Ramsey
TI  - A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells
SN  - 1949-2553
PY  - 2017///0131
KW  - Aniline Compounds
KW  - administration & dosage
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Benzothiazoles
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Proliferation
KW  - drug effects
KW  - Combined Modality Therapy
KW  - DNA-Binding Proteins
KW  - antagonists & inhibitors
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Mice
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - RNA, Small Interfering
KW  - Receptor, ErbB-2
KW  - biosynthesis
KW  - Transcription Factors
KW  - Transfection
KW  - Trastuzumab
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.7944
ER  -